MedTrace Logo

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease

NCT00829738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4188

Last updated 2012-05-08

Study results available
· View outcomes & findings →

Summary

The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population.

Conditions

  • Gastroesophageal Reflux Disease

Interventions

DRUG

Pantoprazole

This was an observational study. Therefore, the physician decided about dosage according to individual needs (20 or 40 mg pantoprazole).

Sponsors & Collaborators

  • Nycomed

    lead INDUSTRY

Principal Investigators

  • Thomas D. Bethke, MD, MBA · Nycomed Deutschland GmbH, 78467 Konstanz, Germany

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-04-30
Completion
2009-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00829738 on ClinicalTrials.gov